Oct 22, 2019—New York, US Gene and cell therapy has entered an era of mass progress, marked by advancement in the gene technology, which receives optimistic results in several diseases, such as adrenoleukodystrophy, hemophilia IX, β-thalassemia, malignant glioblastoma, leukemia and some cancers. To pander to the new chance and challenge that the novel gene therapy products have brought about in the clinical arena already, Creative Biolabs has developed a series of one-stop solutions and associated STEMOD™ disease models to support all stem cell therapy relevant projects from clients on a worldwide scale.
Provided solutions are classified into three categories according to different research purposes, i.e. Basic Research Services, Stem Cell Therapy Development Services and Stem Cell Manufacturing Services, accepting embryonic stem cells, pluripotent stem cells and mesenchymal stem cells, etc.
Projects regarding induced pluripotent stem cell (iPSC) and mesenchymal stem cell (MSC) can find enhancers at Creative Biolabs on aspects of reprogramming, culture, characterization, genome editing and differentiation operations, which are customizable and ensured for a quick (16-24 weeks) but highly qualified delivery, together with considerate scientific support. Involving techniques are streamed-line protocols, iPSC-focused media, gene expression models and so on.
Another crucial component of the solutions receiving high popularity in the industry is the organoid and 3D bioprinting service, focusing on the problems resulting from a shortage of available organs for transplantation. By taking advantage of Creative Biolabs’s most up-to-date organoids—cell-derived in vitro 3D organ models and a fabrication technology—3D bioprinting, creation of human tissues, including skin, bone, cartilage, even blood vessels, for patients and victims becomes possible, which also brings hope to the organ development and replacement.
Creative Biolabs, as an expert in the design & manufacturing of small molecules and therapeutic methods, also accepts orders regarding stem cell therapy development and stem cell manufacturing. Additionally, a series of iPSC models of human diseases are provided based upon the STEMOD™ disease model platform, covering the cardiovascular system, nervous system, ocular system, etc.
Holding over a decade of experience in serving high-end products and services in the field of biopharmaceuticals for global clients, scientists at Creative Biolabs will be more concentrated on designing and developing first-class products and technologies to meet requirements of stem cell therapy development, and finally, to promote the progress of precision medicine. If more information about Creative Biolabs or the stem cell therapy development solutions is required, please visit https://www.creative-biolabs.com/stem-cell-therapy/.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States